Clinical Trial Update: Direct Endomyocardial Injection of Autologous Bone Marrow Cells to Treat Ischaemic Heart Failure [Phase 2]

View source ↗

Summary

This document provides an update on a Phase 2 clinical trial evaluating direct endomyocardial injection of autologous bone marrow cells to treat ischemic heart …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Ischemic Heart Failure

Drugs mentioned

• Autologous bone marrow cells

Snippet

Sponsor: The University of Hong Kong | Conditions: Coronary Artery Disease | Phase 2 | Status: UNKNOWN